Publisher Correction: A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk

Affiliations

• ¹ Department of Cardiovascular & Metabolic Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.
• ² Systems Biology and Bioinformatics Program, Department of Nutrition, Case Western Reserve University, Cleveland, OH, USA.
• ³ Department of Cardiology, Angiology and Intensive Care, Deutsches Herzzentrum der Charité, Campus Benjamin Franklin, Berlin, Germany.
• ⁴ Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
• ⁵ Department of Biochemistry & Molecular Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
• ⁶ German Center for Cardiovascular Research (DZHK), Partner Site Berlin, Berlin, Germany.
• ⁷ Berlin Institute of Health (BIH), Berlin, Germany.
• ⁸ Friede Springer Cardiovascular Prevention Center at Charité, Berlin, Germany.
• ⁹ Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
• ¹⁰ West Coast Metabolomics Center, University of California, Davis, Davis, CA, USA.
• ¹¹ Institute of Physiology of the Czech Academy of Sciences, Prague, Czech Republic.
• ¹² Department of Endocrinology and Metabolism, Charité - Universitätsmedizin Berlin, Berlin, Germany.
• ¹³ Berlin Institute of Health Center for Regenerative Therapies, Berlin, Germany.
• ¹⁴ Department of Cardiovascular Medicine, Heart, Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, OH, USA.
• ¹⁵ Department of Cardiovascular & Metabolic Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA. hazens@ccf.org.
• ¹⁶ Department of Cardiovascular Medicine, Heart, Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, OH, USA. hazens@ccf.org.